According to the first few clinical experiences in small NPM1m AML patient series, ddPCR demonstrated excellent sensitivity and agreement with RQ-PCR, also allowing for the detection of a variety of rare NPM1 mutation subtypes [18,19]. Here, NPM1 is linked to acute myeloid leukemia.